95561-18-5

Basic information

• Product Name: N‐{[(4‐methylphenyl)sulfonyl]oxy}‐2‐(3,4‐dimethoxyphenyl)‐2,3‐dihydro‐4H‐chromen‐4‐imine
• Synonyms: N‐{[(4‐methylphenyl)sulfonyl]oxy}‐2‐(3,4‐dimethoxyphenyl)‐2,3‐dihydro‐4H‐chromen‐4‐imine
• CAS NO: 95561-18-5
• Molecular Weight: 453.516
• Mol File: 95561-18-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N‐{[(4‐methylphenyl)sulfonyl]oxy}‐2‐(3,4‐dimethoxyphenyl)‐2,3‐dihydro‐4H‐chromen‐4‐imine(CAS DataBase Reference)
• NIST Chemistry Reference: N‐{[(4‐methylphenyl)sulfonyl]oxy}‐2‐(3,4‐dimethoxyphenyl)‐2,3‐dihydro‐4H‐chromen‐4‐imine(95561-18-5)
• EPA Substance Registry System: N‐{[(4‐methylphenyl)sulfonyl]oxy}‐2‐(3,4‐dimethoxyphenyl)‐2,3‐dihydro‐4H‐chromen‐4‐imine(95561-18-5)

Safety Data

• Hazardous Substances Data: 95561-18-5(Hazardous Substances Data)

Upstream product

• 79140-20-8 2'-hydroxy-3,4-dimethoxychalcone 
• 120-14-9 3,4-dimethoxy-benzaldehyde 
• 118-93-4 o-hydroxyacetophenone 
• 6344-21-4 3',4'-dimethoxyflavanone 
• 65612-72-8 2-(3,4-dimethoxy-phenyl)-chroman-4-one oxime 
• 98-59-9 p-toluenesulfonyl chloride 

Relevant articles and documents

Synthesis and hplc-ecd study of cytostatic condensed o,n-heterocycles obtained from 3-aminoflavanones

Racemic chiral O,N-heterocycles containing 2-arylchroman or 2-aryl-2H-chromene subunit condensed with morpholine, thiazole, or pyrrole moieties at the C-3-C-4 bond were synthesized with various substitution patterns of the aryl group by the cyclization of cis- or trans-3- aminoflavanone analogues. The 3-aminoflavanone precursors were obtained in a Neber rearrangement of oxime tosylates of flavanones, which provided the trans diastereomer as the major product and enabled the isolation of both the cis- and trans-diastereomers. The cis- and transaminoflavanones were utilized to prepare three diastereomers of 5-aryl-chromeno[4,3- b][1,4]oxazines. Antiproliferative activity of the condensed heterocycles and precursors was evaluated against A2780 and WM35 cancer cell lines. For a 3-(N-chloroacetylamino)-flavan-4-ol derivative, showing structural analogy with acyclic acid ceramidase inhibitors, 0.15 μM, 3.50 μM, and 6.06 μM IC50 values were measured against A2780, WM35, and HaCat cell lines, and apoptotic mechanism was confirmed. Low micromolar IC50 values down to 2.14 μM were identified for the thiazole- and pyrrole-condensed 2H-chromene derivatives. Enantiomers of the condensed heterocycles were separated by HPLC using chiral stationary phase, HPLC-ECD spectra were recorded and TDDFT-ECD calculations were performed to determine the absolute configuration and solution conformation. Characteristic ECD transitions of the separated enantiomers were correlated with the absolute configuration and effect of substitution pattern on the HPLC elution order was determined.